Table 2. Comparison of health examination among women aged 50-70 years by region and area type — 6 provinces, China, 2018.
| Health examination |
Total
n (%, 95% CI) |
Region | Area type | ||||||||
|
Eastern
n (%, 95% CI) |
Central
n (%, 95% CI) |
Western
n (%, 95% CI) |
χ2 | P |
Urban
n (%, 95% CI) |
Rural
n (%, 95% CI) |
χ2 | P | |||
| Regular physical examination | |||||||||||
| Never had | 2,245
(46.4, 45.0−47.8) |
648
(39.4, 37.0−41.8) |
771
(47.8, 45.4−50.3) |
826
(52.3, 49.8−54.8) |
33.299 | <0.001 | 1,103
(46.1, 44.1−48.1) |
1,142
(46.7, 44.7−48.7) |
1.355 | 0.244 | |
| Ever had within 1 year | 1573
(32.5, 31.2−33.8) |
673
(40.9, 38.5−43.3) |
454
(28.2, 26.0−30.4) |
446
(28.2, 26.0−30.5) |
94.934 | <0.001 | 673
(28.1, 26.3−30.0) |
900
(36.8, 34.9−38.7) |
65.517 | <0.001 | |
| Ever had within 1–3 years | 945
(19.5, 18.4−20.7) |
303
(18.4, 16.5−20.3) |
366
(22.7, 20.7−24.8) |
276
(17.5, 15.6−19.4) |
20.314 | <0.001 | 569
(23.8, 22.1−25.5) |
376
(15.4, 13.9−16.8) |
78.834 | <0.001 | |
| Ever had >3 years | 73
(1.5, 1.2−1.9) |
21
(1.3, 0.7−1.8) |
21
(1.3, 0.7−1.9) |
31
(2.0, 1.3−2.6) |
3.976 | 0.137 | 46
(1.9, 1.4−2.5) |
27
(1.1, 0.7−1.5) |
9.890 | 0.002 | |
| Breast and cervical cancer screening | |||||||||||
| Never had | 3,230
(64.2, 62.9−65.6) |
991
(58.3, 56.0−60.7) |
1,003
(60.5, 58.1−62.9) |
1,236
(73.9, 71.8−76.0) |
53.154 | <0.001 | 1,618
(64.4, 62.5−66.3) |
1,612
(64.0, 62.2−65.9) |
0.022 | 0.881 | |
| Had screening for one cancer | 401
(8.0, 7.2−8.7) |
143
(8.4, 7.1−9.7) |
67
(4.0, 3.1−5.0) |
191
(11.4, 9.9−12.9) |
87.741 | <0.001 | 163
(6.5, 5.5−7.5) |
238
(9.5, 8.3−10.6) |
28.055 | <0.001 | |
| Had screening for both cancers | 1,398
(27.8, 26.6−29.0) |
565
(33.3, 31.0−35.5) |
588
(35.5, 33.2−37.8) |
245
(14.7, 13.0−16.3) |
236.672 | <0.001 | 731
(29.1, 27.3−30.9) |
667
(26.5, 24.8−28.2) |
5.860 | 0.015 | |
| Cervical cancer screening | |||||||||||
| Never had | 3,388
(67.7, 66.4−68.9) |
1,056
(62.3, 60.0−64.6) |
1,044
(63.2, 60.9−65.5) |
1,288
(77.6, 75.6−79.6) |
50.253 | <0.001 | 1,737
(69.6, 67.8−71.4) |
1,651
(65.8, 63.9−67.6) |
4.366 | 0.037 | |
| Ever had within 1 year | 822
(16.4, 15.4−17.4) |
365
(21.5, 19.6−23.5) |
284
(17.2, 15.4−19.0) |
172
(10.4, 8.9−11.8) |
102.898 | <0.001 | 344
(13.8, 12.4−15.1) |
478
(19.0, 17.5−20.6) |
43.689 | <0.001 | |
| Ever had within 1–3 years | 516
(10.3, 9.5−11.1) |
168
(9.9, 8.5−11.3) |
220
(13.3, 11.7−15.0) |
128
(7.7, 6.4−9.0) |
37.116 | <0.001 | 268
(10.7, 9.5−11.9) |
248
(9.9, 8.7−11.0) |
1.550 | 0.213 | |
| Ever had >3 years | 282
(5.6, 5.0−6.3) |
106
(6.3, 5.1−7.4) |
104
(6.3, 5.1−7.5) |
72
(4.3, 3.4−5.3) |
11.617 | 0.003 | 148
(5.9, 5.0−6.9) |
134
(5.3, 4.5−6.2) |
1.390 | 0.238 | |
| Breast cancer screening | |||||||||||
| Never had | 3,523
(70.3, 69.0−71.6) |
1,097
(64.6, 62.4−66.9) |
1,034
(62.5, 60.2−64.9) |
1,392
(83.8, 82.0−85.6) |
93.312 | <0.001 | 1,690
(67.7, 65.8−69.5) |
1,833
(72.9, 71.1−74.6) |
11.609 | 0.001 | |
| Ever had within 1 year | 760
(15.2, 14.2−16.2) |
325
(19.2, 17.3−21.0) |
307
(18.6, 16.7−20.4) |
128
(7.7, 6.4−9.0) |
140.475 | <0.001 | 396
(15.9, 14.4−17.3) |
364
(14.5, 13.1−15.8) |
2.695 | 0.101 | |
| Ever had within 1–3 years | 444
(8.9, 8.1−9.6) |
158
(9.3, 7.9−10.7) |
210
(12.7, 11.1−14.3) |
76
(4.6, 3.6−5.6) |
92.514 | <0.001 | 253
(10.1, 8.9−11.3) |
191
(7.6, 6.6−8.6) |
17.315 | <0.001 | |
| Ever had >3 years | 285
(5.7, 5.0−6.3) |
117
(6.9, 5.7−8.1) |
103
(6.2, 5.1−7.4) |
65
(3.9, 3.0−4.8) |
22.863 | <0.001 | 158
(6.3, 5.4−7.3) |
127
(5.0, 4.2−5.9) |
6.744 | 0.009 | |